Niraparib/TTFields in GBM
Clinical trial NCT04221503 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04221503
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-30
- Primary completion
- 2026-01-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.